Gastroduodenal permeability in Crohn's disease

European Journal of Clinical Investigation

Volumn 28, Issue 1, 1998, Pages 67-71

  Puspok A ^a,b   Oberhuber, G ^a   Wyatt, J ^a   Maier Dobersberger, T ^a   Hammer, J ^a   Pfeffel, F ^a   Wrba, F ^a   Potzi R ^a   Vogelsang, H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Crohn's disease; Histology; Lactulose; Mannitol; Permeability; Sucrose

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; SALICYLIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GASTROINTESTINAL BIOPSY; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL MEMBRANE PERMEABILITY; CROHN DISEASE; DUODENUM; FEMALE; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUCROSE;

EID: 0031929185     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00241.x     Document Type: Article

References (25)

1. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology, 1993; 104: 1619-1626.
2. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB. A simple non-invasive marker of gastric damage: sucrose permeability. Lancet, 1994; 343: 998-1000.
3. Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients. Pathology and Research Practices, 1985; 179: 377-387.
4. Lenaerts C, Roy CC, Vaillancourt M, Weber AM, Morin CL, Seidman E. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics, 1989; 83: 777-781.
5. Korelitz BI, Waye JD, Kreuning J, et al. Crohn's disease in endoscopie biopsies of the gastric antrum and duodenum. American Journal of Gastroenterology, 1981; 76: 103-109.
6. Alcántara M, Rodriguez R, Potenciano JLM, Carrobles JL, Munoz C, Gomez R. Endoscopie and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease. Endoscopy, 1993; 25: 282-286.
7. Mashako MN, Cezard JP, Navarro J, et al. Crohn's disease lesions in the upper gastrointestinal tract: correlation between clinical radiological, endoscopie and histological features in adolescents and children. Journal of Pediatric Gastroenterology and Nutrition, 1989; 8: 442-446.
8. Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of Helicobacter negative gastritis in patients with Crohn's disease. Gut, 1996; 38: 379-383.
9. Oberhuber G, Püspök A, Oesterreicher Ch, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology, 1997; 112: 698-706.
10. Lennard-Jones JE. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 1989; 24: (suppl. 170): 2-5.
11. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 1976; 70: 439-444.
12. Dixon MF, Genta RM, Yardley JH, Correa P, and the participants in the International Workshop on the histopathology of gastritis. Classification and grading of gastritis: the updated Sydney system. American Journal of Surgery and Pathology, 1996; 20: 1161-1181.
13. Vogelsang H, Oberhuber G, Wyatt J. Lymphocytic Gastritis and gastric permeability in patients with celiac disease. Gastroenterology, 1996; 111: 73-77.
14. Wyatt J, Vogelsang H, Hübl W, Waldhör T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet, 1993; 341: 1437-1439.
15. André F, André C, Emery Y, Forichon J, Descos L, Minaire Y. Assessment of the lactulose-mannitol test in Crohn's disease. Gut, 1988; 29: 511-515.
16. 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology, 1983; 85: 318-322.
17. 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. American Journal of Gastroenterology, 1987; 82: 1159-1164.
18. Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology, 1996; 110: 1395-1403.
19. Gryboski JD, Thayer WR, Gabrielson IW, Spiro HM. Disacchariduria in gastrointestinal disease. Gastroenterology, 1963; 45: 633-637.
20. Dunne WT, Cooke WT, Allan RN. Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract. Gut, 1977; 18: 290-294.
21. Arvanitakis C. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease. Digestion, 1979; 19: 259-266.
22. Bolin T, Heuman R, Sjodahl R, Tagesson C. Decreased lysophospholipase and increased phospholipase A2 activity in ileal mucosa from patients with Crohn's disease. Digestion, 1984; 29: 55-59.
23. Jönsson KA, Bodemar G, Tagesson C, Walan A. Variation of disaccharidase activities in duodenal biopsy specimens. Scandinavian Journal of Gastroenterology, 1986; 21: 51-54.
24. Lembcke B, Schneider H, Lankisch PG. Is the assay of disaccharidase activity in small bowel mucosal biopsy relevant for clinical gastroenterologists? Klinische Wochenschrift, 1989; 67: 568-575.
25. Park RH, Duncan A, Russell RI. Hypolactasia in Crohn's disease: a myth. American Journal of Gastroenterology, 1990; 85: 708-710.